MELISSA MONSOUR ATKINS

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family COLUMBUS, MS NPI 1588325823

General Payments — all program years on this page

$1,233.97

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 75
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $368.46 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $368.4621

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2022 $225.5114
2023 $640.0040
2024 $368.4621

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086285896 Bayer Healthcare Pharmaceuticals Inc. $14.41 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100297547 Novo Nordisk Inc $19.54 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100461532 Novo Nordisk Inc $15.14 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100570838 Novo Nordisk Inc $22.05 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104257633 AstraZeneca Pharmaceuticals LP $18.44 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104418069 AstraZeneca Pharmaceuticals LP $16.88 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104676207 AstraZeneca Pharmaceuticals LP $16.70 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104765800 AstraZeneca Pharmaceuticals LP $17.63 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105336840 AstraZeneca Pharmaceuticals LP $14.78 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105612931 AstraZeneca Pharmaceuticals LP $14.53 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105730825 AstraZeneca Pharmaceuticals LP $14.98 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106459468 ABBVIE INC. $16.06 03/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106459470 ABBVIE INC. $23.27 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114534061 Exact Sciences Corporation $18.28 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117193499 Amgen Inc. $20.42 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117193501 Amgen Inc. $16.84 09/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117193503 Amgen Inc. $19.31 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118069308 Boehringer Ingelheim Pharmaceuticals, Inc. $16.84 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151146056 Phathom Pharmaceuticals, Inc. $18.87 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151146058 Phathom Pharmaceuticals, Inc. $17.68 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151146060 Phathom Pharmaceuticals, Inc. $15.81 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.